Product Launch Recently launched an injectable balloon catheter for below-the-knee peripheral artery disease, presenting a clear entry point for interventional markets and hospital procurement discussions.

Urban Presence Headquartered in Cambridge, MA with proximity to major medical centers and research institutions, enabling strategic partnerships, pilots, and clinical collaborations in a high-access, innovation-forward ecosystem.

Early Revenue Stage Current revenue band is zero to one million dollars, suggesting a startup-ready profile with growth potential through device adoption, reimbursement navigation, and strategic channel partnerships.

Product Roadmap Plan to launch a redesigned product line in late 2024 and expand in the U.S. and select international markets, indicating opportunities for portfolio expansion deals, SKU bundling, and regional sales initiatives.

Clinical & Payer Value Focus on improving efficacy, safety, and cost-efficiency of leg revascularization aligns with value-based purchasing trends and potential collaborations with hospitals, distributors, and payer-focused programs.